Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase I, Multicenter, Open-label, First-in-Human, Dose Escalation and Expansion Study of AZD9592 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumors
This is a first-in-human (FIH) Phase I, multi-center, open-label, study of AZD9592, in patients with advanced solid tumors. The study consists of several study…
Advanced Solid TumoursCarcinoma Non-small Cell LungHead and Neck Neoplasms+1 more
AstraZenecaNCT05647122
Phase 1
A Phase 1A/B Study To Evaluate The Safety And Tolerability Of EBC-129 As A Single Agent And In Combination With Pembrolizumab In Advanced Solid Tumours
This study will assess the safety and tolerability of EBC-129 as a single agent and in combination with pembrolizumab in patients with advanced solid tumours
Advanced Solid Tumours
EDDC (Experimental Drug Development Centre), A*STAR Research EntitiesNCT05701527